Total planned funding: $878,340,950
Clear active filters
Unknown
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $137,423,441 |
Kenya | $133,617,711 |
Tanzania | $127,914,138 |
Uganda | $92,972,932 |
Nigeria | $72,540,078 |
Côte d'Ivoire | $44,088,831 |
Ethiopia | $43,478,998 |
Mozambique | $27,424,704 |
South Africa | $26,118,582 |
Lesotho | $18,078,915 |
Democratic Republic of the Congo | $15,639,376 |
Ukraine | $14,750,220 |
Eswatini | $13,916,644 |
Cameroon | $13,550,538 |
Central America Region | $13,016,795 |
Zimbabwe | $13,000,539 |
Namibia | $9,077,652 |
Haiti | $8,358,710 |
Malawi | $7,457,213 |
India | $5,250,000 |
Rwanda | $5,013,456 |
Central Asia Region | $4,993,326 |
Ghana | $4,761,377 |
Burundi | $4,119,637 |
Botswana | $4,089,983 |
Burma | $3,975,000 |
Cambodia | $3,823,846 |
Caribbean Region | $1,970,317 |
Asia Regional Program | $1,908,157 |
Papua New Guinea | $1,809,199 |
Vietnam | $1,785,326 |
Dominican Republic | $853,131 |
Guyana | $650,000 |
Indonesia | $500,000 |
South Sudan | $412,178 |
Organizational Types
Unknown | $878,340,950 |
Program Areas
Treatment | $301,505,174 |
Care | $232,609,605 |
Prevention | $165,723,919 |
Governance and Systems | $91,747,766 |
Testing | $85,663,470 |
Budget Codes
HTXS: Treatment: Adult Treatment | $259,400,676 |
HKID: Care: Orphans and Vulnerable Children | $121,082,120 |
HVCT: Testing: HIV Testing and Counseling | $85,663,470 |
HVOP: Sexual Prevention: Other Sexual Prevention | $64,983,082 |
HBHC: Care: Adult Care and Support | $61,749,376 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $48,641,904 |
HVSI: Strategic Information | $41,208,111 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $34,879,149 |
HVTB: Care: TB/HIV | $32,527,872 |
OHSS: Health Systems Strengthening | $31,738,666 |
PDTX: Treatment: Pediatric Treatment | $26,788,193 |
HLAB: Laboratory Infrastructure | $18,800,989 |
PDCS: Care: Pediatric Care and Support | $17,250,237 |
HTXD: Treatment: ARV Drugs | $15,316,305 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,687,540 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,166,233 |
HMIN: Biomedical Prevention: Injection Safety | $2,625,071 |
HMBL: Biomedical Prevention: Blood Safety | $740,940 |